Sorrentino, J., Martínez-Bartolomé, S., Abbasian, M., Koller, A., Hickman, D., Khalil, A., Pandit, N., Horrigan, K., Percival, M., Stirewalt, D., Quintas-Cardama, A., Jackson, P. (2025). Machine learning-powered integration of global proteomics and ex vivo sensitivity unveils a protein signature predictive of treatment success to AML therapy: Validation in patients treated with FHD-286, a SMARCA2/4 dual inhibitor. Blood. https://doi.org/10.1182/blood-2025-3498